Maraviroc (Celsentri) for multidrug-resistant human immunodeficiency virus (HIV)-1

Canadian Agency for Drugs and Technologies in Health
Record ID 32008100186
English
Details
Project Status: Completed
URL for project: http://cadth.ca
Year Published: 2007
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Adult
  • Canada
  • CD4 Lymphocyte Count
  • Jurisprudence
  • Europe
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • United States
  • Viral Load
  • Anti-HIV Agents
  • Anti-Retroviral Agents
  • Cyclohexanes
  • Drug Approval
  • Drug Resistance, Viral
  • HIV Fusion Inhibitors
  • HIV Infections
  • HIV-1
  • Lymphocytes
  • Receptors, CCR5
  • Receptors, CXCR4
  • Triazoles
  • Tropism
Contact
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name: requests@cadth.ca
Contact Email: requests@cadth.ca
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.